Health Catalyst, Inc. announced impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported impairment of long-lived assets of $2,200,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 USD | -2.92% | -5.41% | -28.19% |
05-10 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
05-09 | Health Catalyst Seeks M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.19% | 393M | |
-18.99% | 217B | |
-5.49% | 69.21B | |
-0.10% | 58.3B | |
-11.63% | 46.03B | |
+0.61% | 40.85B | |
-1.76% | 35.93B | |
-9.56% | 28.65B | |
+98.90% | 26.08B | |
+4.37% | 21.87B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024